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Capsid coding sequences of foot-and-mouth
disease viruses are determinants of pathogenicity
in pigs
Louise Lohse1*, Terry Jackson2, Anette Bøtner1 and Graham J Belsham1
Abstract
The surface exposed capsid proteins, VP1, VP2 and VP3, of foot-and-mouth disease virus (FMDV) determine its
antigenicity and the ability of the virus to interact with host-cell receptors. Hence, modification of these structural
proteins may alter the properties of the virus.
In the present study we compared the pathogenicity of different FMDVs in young pigs. In total 32 pigs,
7-weeks-old, were exposed to virus, either by direct inoculation or through contact with inoculated pigs, using
cell culture adapted (O1K B64), chimeric (O1K/A-TUR and O1K/O-UKG) or field strain (O-UKG/34/2001) viruses. The
O1K B64 virus and the two chimeric viruses are identical to each other except for the capsid coding region.
Animals exposed to O1K B64 did not exhibit signs of disease, while pigs exposed to each of the other viruses
showed typical clinical signs of foot-and-mouth disease (FMD). All pigs infected with the O1K/O-UKG chimera or
the field strain (O-UKG/34/2001) developed fulminant disease. Furthermore, 3 of 4 in-contact pigs exposed to the
O1K/O-UKG virus died in the acute phase of infection, likely from myocardial infection. However, in the group
exposed to the O1K/A-TUR chimeric virus, only 1 pig showed symptoms of disease within the time frame of the
experiment (10 days). All pigs that developed clinical disease showed a high level of viral RNA in serum and
infected pigs that survived the acute phase of infection developed a serotype specific antibody response. It is
concluded that the capsid coding sequences are determinants of FMDV pathogenicity in pigs.
Introduction
Foot-and-mouth disease (FMD) is one of the world’s
most economically important infectious diseases of farm
animals including cattle, pigs and sheep. The aetiological
agent of FMD is foot-and-mouth disease virus (FMDV)
which is the prototype Aphthovirus within the family
Picornaviridae. The virus can infect about 70 different
wild life species and can spread rapidly causing high
morbidity but only low mortality except in young ani-
mals [1]. The severity of the disease varies between hosts
with pigs and cattle exhibiting clear clinical signs while
infection in sheep is often difficult to detect by clinical
observation. The disease in cattle and pigs follows a
rapid time course and causes a rise in body temperature
and the development of vesicular lesions in and around
the mouth and on the feet. Infected animals display
varying degrees of salivation, inappetence and lameness
according to the severity of lesions. The clinical course
of the infection usually subsides within 7–14 days and is
accompanied by a rapid generation of neutralizing anti-
bodies within the serum. However, many animals can
subsequently “carry” the virus in the oropharynx for a
prolonged period; this “carrier state” can be maintained
for several months (in sheep) or years (in cattle and buf-
falo). In general it is considered that pigs do not become
carriers [1] although there is some evidence to the con-
trary [2-4].
FMDV exists in 7 distinct serotypes, O, A, C, SAT1,
SAT2, SAT3 and Asia-1. Each virus particle contains a
positive sense single-stranded RNA genome of about
8.4 kb enclosed within a protein shell consisting of 60
copies each of the 4 capsid proteins 1A (VP4), 1B (VP2),
1C (VP3) and 1D (VP1) [5]. VP1, VP2 and VP3 are
exposed on the outer surface of the virus particle and
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hence they determine both the antigenicity of the virus
and its ability to interact with specific receptors on cells.
The major cellular receptor for FMDV is believed to
be the integrin αvβ6 which is expressed on epithelial
cells [6-8] but other RGD-binding integrins, (αvβ8, αvβ1
and αvβ3), have also been shown to function as recep-
tors for FMDV in cell culture [8-11]. Cell culture
adapted serotype O viruses can also bind to cells via
heparan sulfate (HS) and can use this interaction to initi-
ate infection. The ability to bind to HS is associated with
specific amino acid substitutions (including His56 to
Arg56 in VP3) on the surface of the virus [12-14]. How-
ever, the HS binding phenotype has been linked to at-
tenuation of serotype O virus in cattle [14,15].
Different strains of FMDV can vary greatly in their
pathogenicity within different host species. For instance,
some virus strains (e.g. O/Taiwan 1997) cause disease in
pigs but not in cattle (i.e. the porcinophilic strains) [16].
Some of these viruses (namely O/Taiwan 1997) have
been shown to contain a deletion within the coding re-
gion for the 3A protein [17,18]; however, other porcino-
philic strains from Korea (O/SKR/AS/2002) had an
intact 3A coding region [19].
Full-length infectious cDNAs corresponding to the
FMDV genome have been produced for serotype O [20-
22] and serotype A [23,24] viruses. These have permitted
the construction of chimeric full-length infectious
FMDV cDNAs in which the capsid coding sequences of
one virus has been replaced with the equivalent coding
region of a different virus. Viable chimeric viruses have
been rescued from these cDNAs and been shown to dis-
play the antigenicity of the introduced capsid sequences
[14,15,25,26].
Previously we have replaced the coding region for the
surface exposed capsid proteins (VP1, VP2 and VP3) of
an infectious cDNA derived from a cell culture adapted,
HS-binding, strain of O1 Kaufbeuren (O1K B64)
(pT7S3, see [22]) with the corresponding region of field
strains of serotype O (O/UKG/34/2001) or serotype A
(A-Tur/06) viruses [15]. Thus the chimeric viruses
obtained (O1K/O-UKG and O1K/A-Tur) and the paren-
tal O1K B64 are identical to each other except for the
capsid coding region. In the previous study, these
chimeric viruses were shown to be pathogenic in cattle
whereas the parental O1K B64 strain is completely atte-
nuated in this host [15]. Thus the production of
chimeric viruses can be a useful tool for identifying
determinants of pathogenicity.
Since the pathogenicity of FMDVs can vary between
hosts we have now determined the virulence of these
chimeric viruses and their parent (O1K B64) within pigs
as well. For comparison the O/UKG/34/2001 field virus
was tested in parallel. This virus produces a relatively
mild form of the disease in cattle [27] but has also been
well characterized within experimental studies in pigs in
which it causes quite severe disease [28,29].
Here we report that the rescued cell culture adapted
O1K B64 virus is also highly attenuated in pigs. How-
ever, the two chimeric virus derivatives, O1K/O-UKG
and O1K/A-TUR, were able to cause typical clinical
signs of FMD in inoculated pigs albeit with different effi-
ciencies. Some young pigs infected by contact exposure
to the O1K/O-UKG chimera died suddenly during the
acute phase of infection. These studies show that the
capsid coding sequences are determinants of FMDV
pathogenicity in pigs.
Material and methods
Animal experiments and samples
Experimental procedures and animal management pro-
tocols were carried out in accordance with the require-
ments of the Danish Animal Experimentation
Inspectorate, license no. 2008/561-1541. All pigs were
housed in the high containment BSL3+ experimental fa-
cilities at the National Veterinary Institute, Lindholm.
In total, 32 weaner pigs (7 weeks of age) were obtained
from a conventional Danish swine herd with specific
pathogen free (SPF) status, including freedom from en-
zootic pneumoniae, atrophic rhinitis, swine dysentery,
porcine reproductive and respiratory syndrome and
most serotypes of pleuropneumoniae. All pigs were
found to be healthy by veterinary inspection on arrival at
the Institute, 1 week before the start of the experiment.
All pigs were fed a commercial diet for weaning pigs and
water was provided ad libitum. Straw was used for
bedding.
Pigs were randomly divided into 4 groups of 8 pigs
and the individual groups were kept in separate pens
with no physical contact between them. Groups 1 and 2,
in one stable, shared the same air space while Groups 3
and 4, in another stable, also shared air space with each
other. Four pigs in each group were inoculated with the
different FMDVs: Group 1 was inoculated with the cell
culture adapted B64 strain of the O1 Kaufbeuren virus
(O1K B64); Group 2, was inoculated with the O1K/A-
TUR chimeric virus [15], a derivative of O1K B64 con-
taining the surface exposed capsid proteins (VP1, VP2
and VP3) from A/Turkey 2/2006; Group 3 was inocu-
lated with a second chimeric virus (O1K/O-UKG) [15]
also derived from O1K B64 and containing VP1, VP2
and VP3 from O UKG/34/2001 and Group 4 was inocu-
lated with the field strain O UKG/34/2001, as used pre-
viously at Lindholm, in cattle by Stenfeldt et al. [27].
Inoculation was performed in the heel bulb, each pig re-
ceiving approximately 105 TCID50 in a volume of
0.3 mL. All inoculated pigs were anaesthetized during
the process. The remaining four pigs in each group were
left as in-contact animals.
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On each subsequent day, all pigs were examined for
clinical signs of FMD, to generate a clinical score, and
rectal body temperatures were recorded. Clinical scores
(CS) were assigned based on a semi-quantitative scoring
system with each animal being assessed on 4 FMD-
relevant parameters (general well-being, appetite, lame-
ness and the presence of lesions on the mouth/nose/
tongue and feet). Body weight was recorded on arrival at
the Institute and at the termination of the experiment.
Blood samples were collected from the jugular vein on
the following days post infection (dpi) 0, 1, 2, 3, 4, 5, 7
and 10 for inoculated pigs and on dpi 0, 4, 5, 6, 7, 8, 9
and 10 for contact pigs. Oral swab samples were col-
lected at the same times. Pigs, which developed signifi-
cant lesions, were treated with analgesics. Pigs that
displayed clinical symptoms which reached the humane
endpoint criteria during the course of the experiment,
were euthanised when necessary and, after 10 days, sur-
viving pigs were euthanised by intravenous injection of
sodium pentobarbital. All pigs were autopsied and rele-
vant tissues were collected for further examination.
Quantification of anti-FMDV antibodies using a solid
phase blocking ELISA
Serum samples were screened for antibodies to FMDV
in a solid phase blocking ELISA [30,31]. In brief, micro-
titre plates were coated with guinea-pig immune serum
raised against FMDV serotype O or serotype A, as ap-
propriate, before addition of the respective inactivated
FMDV antigen. Test serum samples were then added
and incubated overnight, the plates were washed and
then rabbit anti-FMDV serotype O or A serum was
added. Bound rabbit antibodies were detected with
horseradish-peroxidase conjugated pig anti-rabbit IgG
(Dakopatts P0217, DakoCytomation, Denmark A/S). All
serum samples were initially screened at a dilution of 1:5
and positive samples were further analyzed in a two-fold
titration, starting at a dilution of 1:10 to allow determin-
ation of antibody titers.
Quantification of viral RNA using a quantitative real time
RT-PCR
FMDV RNA in serum, oral swabs and heart tissue was
determined using a quantitative real-time RT-PCR assay
[32] which is targeted to the 5'-untranslated region of
the viral RNA. In brief, total RNA was extracted from
200 μL of sample using a MagNa Pure LC Total Nucleic
Acid Isolation Kit (Roche) according to the manufac-
turer′s instructions in an automated RNA extraction
system. After extraction, each sample was eluted in 50
μL Elution Buffer. cDNA was made using 6 μL of
extracted RNA in a total volume of 15 μL, using a Taq-
Man RT kit mastermix with random hexamer primers
(Applied Biosystems) at 48°C for 45 min and 95°C for
5 min. Seven μL of cDNA was mixed with 18 μL of 2×
TaqMan universal PCR mastermix (Applied Biosystems)
containing 22.5 pmol of each primer and 7.5 pmol of
fluorescently labeled probe. PCR amplification was car-
ried out for 50 cycles in a Thermal cycler (Mx3005P,
Stratagene) and analysed using MxPro qPCR software
(Stratagene). Standard curves were produced using 10-
fold dilutions (100-107) of the synthesis control (an RNA
transcript from a plasmid containing part of the 5′ un-
translated region of FMDV strain O/UKG/34/2001).
Sequencing of viral RNA
To determine if cross contamination between groups
sharing the same air space had occurred, sequencing of
viral RNA isolated from serum and heart tissue from
pigs infected with the O1K/O-UKG (Group 3) and O-
UKG/34/2001 (Group 4) viruses was performed. In brief,
random primed cDNA was made, as described previ-
ously [33] and PCR products corresponding to most of
the VP1 (ca. 520 bp) and to part of the VP4/VP2 coding
regions (ca. 820 bp) were amplified and sequenced in
both directions. Sequences generated were compared to
those known for O1Kaufbeuren [GenBank: X00871] and
O/UKG/35/2001 [GenBank: AJ539141] using BLASTN.
Statistics
Data analysis was performed using GraphPad In Stat
version 3.00 (GraphPad Software, San Diego, CA, USA).
One way ANOVA with post test was selected for com-
parison of mean body weights between groups.
Results
Clinical findings
Four pigs within each of four groups of pigs were inocu-
lated with different FMDVs and, within each group, four
other pigs were left as “in-contact” pigs (see Materials
and methods). Clinical signs of FMD within the pigs var-
ied between the groups exposed to the cell culture
adapted O1KB64, chimeric (O1K/O-UKG and O1K/A-
TUR) or field strain (O-UKG/34/2001) viruses. Clinical
scores for the individual pigs within the 4 groups are
shown in Figure 1. The results show that pigs inoculated
with the cell culture adapted virus, O1K B64, or exposed
to it by direct contact with the inoculated pigs (Group
1), did not develop any clinical signs of FMD. In con-
trast, pigs in each of the 3 other groups developed mod-
erate or severe symptoms of FMD, including vesicular
lesions in the oral cavity and also on the feet (mainly
along the coronary band and in the heel bulb area)
which resulted in lameness. Pigs affected by disease typ-
ically showed slight depression and loss of appetite,
while only sporadic temperature increases in individual
pigs were observed (data not shown).
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In more detail, only one pig in Group 2 (pig 12) which
was inoculated with the chimeric serotype A virus
(O1K/A-TUR) developed severe disease with a max-
imum clinical score of 16 (see Figure 1b). Clinical dis-
ease was not observed in the contact pigs in the 10 day
experiment (but see below). However, all pigs (in Group
3) exposed to the O1K/O-UKG chimeric virus (inocu-
lated and contacts) developed FMD, including vesicles in
the oral cavity and on the feet, with clinical scores of up
to 20 (Figure 1c). In this Group, one inoculated pig (id
no. 22), and 3 of the 4 contact pigs (id nos. 17, 23, 24)
were found dead in the pen only one day after the first
appearance of clinical signs. The remaining contact pig
(id no. 21) did not develop vesicular lesions indicative of
FMD, however, at dpi 10 (the day of termination of the
experiment) lameness was recorded. Pigs in group 4
exposed by inoculation or through contact to the O-
UKG/34/2001 field strain all developed apparent clinical
disease with clinical scores of between 12 and 20
(Figure 1d). Two contact pigs in this group (id nos. 25
and 32) were euthanised on dpi 8 for animal welfare rea-
sons, as administration of analgesics did not appear to
relieve their pain.
Growth rate, defined as the weight difference between
the start and termination of the experiment was calculated
for the individual pigs. Mean weight difference for the 4
groups were compared and no significant difference be-
tween groups were found (p> 0.05; data not shown).
Weight gain for pigs included in the experiment for the
full time period was on average 2.3 kg. Pigs, which died or
were euthanised before the conclusion of the experiment,
were not weighed, however, by visual inspection at the
post mortem (PM) examination these pigs appeared to be
of fair condition.
Autopsy
PM examination revealed mostly lesions or healed
lesions on the feet and in the oral cavity typical of FMD.
In one pig (id no. 11), however, light grey areas on the
left ventricle, compatible with myocardial degeneration
in the heart, was observed. This finding was not related
to any signs of clinical illness, but this pig showed rising
levels of viral RNA in serum (see below) on the last days
before termination of the experiment and could there-
fore have been at risk of acute death from myocardial in-
farction, if the experiment had been prolonged.
Virus detection in serum
The level of FMDV RNA was determined in serum sam-
ples collected at different time points throughout the
course of the experiment (Figure 2). Inoculated pigs,
which showed clinical signs of disease, had high levels of
FMDV RNA (up to 107 genome copies/μL) from dpi 1,
reflecting rapid replication and systemic dissemination
of the virus. For all pigs with clinical symptoms of FMD
(inoculated and contacts) viral RNA was detected in
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Figure 1 Clinical scores (CS) for individual pigs. A CS was assigned to each animal based on 4 FMD-relevant parameters: 1) Well-being:
0 = normal, 1 = depressed; 2) appetite: 0 = normal, 1 = suppressed; 3) mobility: 0 = free movement, 1 = lame, 2 = recumbent; 4) lesions on mouth/
nose/tongue/feet (all 4 feet individually scored): 0 = no lesion, 1 = elevated temperature in local area/congestion/healing vesicle, 2 = vesicle,
3 = ruptured vesicle/severe lesion, in total giving a score between 0 and 25. Inoculated pigs = filled symbols and solid lines, in-contact pigs = open
symbols and dotted lines. † indicates death or euthanasia for welfare reasons. Panel A: Group 1 (O1K B64), panel B: Group 2 (O1K/A-TUR), panel C:
Group 3 (O1K/O-UKG), panel D: Group 4 (O-UKG/34/2001).
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serum for a period of 4–6 days. Typically, viral RNA was
detected in serum for one day before clinical signs
appeared. The results from each Group will be consid-
ered below in more detail.
O1K B64 (Group 1)
No clinical signs of FMD were observed in this group
but one out of 4 pigs (id no. 5) inoculated with the cell
culture adapted virus had detectable but very low
amounts of viral RNA (1.2 genome copies/μL) in serum
for one day only (Figure 2a). All other pigs in this Group
(inoculated and contacts) had no detectable viral RNA
in their serum. Thus there was very limited evidence for
any replication and no sign of any transmission of the
virus from inoculated to contact pigs.
O1K/A-TUR (Group 2)
In the pigs inoculated with the O1K/A-TUR chimeric
virus, one inoculated pig (id no. 12), which showed clin-
ical disease, had relatively high levels of viral RNA in
serum from dpi 1–5 (up to 104 genome copies/μL). One
other inoculated pig (id no. 16) had a very low level of
viral RNA in serum (2.84 genome copies/μL) for one
day after inoculation, however, no clear clinical symp-
toms were ever observed in this pig. In addition, one
contact pig (id no. 11) had rising levels (up to 103 gen-
ome copies/μL) of FMDV RNA, starting at dpi 9
(Figure 2b). However, as the experiment was terminated
on dpi 10, the development of the infection in this pig
could not be followed but, as indicated above, this pig
did exhibit signs of myocardial degeneration in the heart
at autopsy.
O1K/O-UKG (Group 3)
Pigs inoculated with the O1K/O-UKG chimeric virus, all
showed clinical signs of FMD and had viral RNA detect-
able in serum for up to five days. Three out of 4 inocu-
lated pigs (id nos. 18, 19, 22) were positive from dpi 1,
while the fourth (id no. 20) became positive during the
same time period as the contacts, i.e. from dpi 4 and on-
wards. The sudden deaths of one of the inoculated pigs
and three of the four in-contact pigs clearly precluded
detailed analysis of the progression of the infection in
these animals, however, all these 4 pigs had high levels
of FMDV RNA (105 to 107 genome copies/μL) in their
serum on the day before they died (Figure 2c).
O-UKG/34/2001 (Group 4)
In the Group infected with the field strain O-UKG/34/
2001, one inoculated pig (id no. 26) was viral RNA positive
in serum on dpi 1, while the remaining 3 inoculated pigs
(id nos. 28, 29, 30) were positive from dpi 3 (all up to 107
genome copies/μL), see Figure 2d. Contact pigs in this
group were identified as positive for virus RNA from dpi 4
and onwards, but could have been positive at an earlier
time point since the first serum samples from the contact
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Figure 2 Viral RNA in serum, from individual pigs, measured by quantitative real-time RT-PCR expressed as copies of FMDV genome/
μL of serum. Inoculated pigs = filled symbols and solid lines, in-contact pigs = open symbols and dotted lines. Blood samples were collected on
dpi 0, 1, 2, 3, 4, 5, 7 and 10 for inoculated pigs and on dpi 0, 4, 5, 6, 7, 8, 9 and 10 for contact pigs. † indicates death or euthanasia for welfare
reasons. Panel A: Group 1 (O1K B64), panel B: Group 2 (O1K/A-TUR), panel C: Group 3 (O1K/O-UKG), panel D: Group 4 (O-UKG/34/2001).
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pigs were only taken at dpi 4 after the null-sample (for
animal welfare reasons). Therefore we do not know the
true time point for the first appearance of virus in the
blood of contact pigs tested positive on this day.
Whether a delayed infection or transmission of virus
by contact was the case for some of the inoculated pigs
(id nos. 28, 29, 30 in Group 4 and also id no. 20 in
Group 3) that responded “late” (i.e. 3–7 days after inocu-
lation) in this experiment is not clear.
Detection of FMDV RNA in oral swab samples
The level of FMDV RNA in oral swab samples showed a
pattern consistent with the detection of viral RNA in
serum, but at lower levels (c.f. Figure 2 and Figure 3). The
Ct-values indicated about a 100-fold lower virus load in
oral swab samples compared to serum and we believe that
a more precise quantification of the virus in swab samples
from the mouth is not possible (e.g. due to variable level
of salivation etc.). However, detectable viral RNA in oral
swab samples was typically observed over a longer time
span than in serum, often 6–9 days. In fact, for the pigs
containing the highest levels of virus (pigs in Groups 3
and 4) the oral swab samples still contained detectable
levels of FMDV RNA at the day of termination (dpi 10).
Furthermore, FMDV RNA was found at low levels
sporadically in the oral swab samples of several pigs not
going through a systemic FMDV infection in the groups
inoculated with virus of low virulence, i.e. O1K B64 and
O1K/A-TUR infected groups (Figure 3).
FMDV RNA in heart tissue
Due to the sudden death of several pigs from Group 3
(exposed to the O1K/O-UKG chimera), the presence of
FMDV RNA was assayed in heart tissue from pigs infected
with this virus and (for comparison) in samples from pigs
in Group 4 (exposed to the O-UKG/34/2001 field strain).
Based on Ct-values, the pigs could be divided into 3 sets.
The first set was comprised of the pigs that died in the
acute state of infection, after showing initial clinical symp-
toms (id nos. 17, 22, 23, 24). These pigs had high levels of
FMDV RNA (Ct-values = 17–18) in heart tissue as well as
in serum (Ct-values = 14–19). The two other sets included
pigs that survived until the end of the experiment. The
first of these sets included pigs that developed infection
late in the experimental period, i.e. first detectable level of
viral RNA in serum at dpi 7–9 (id nos. 20, 21, 25). These
pigs were positive for detection of FMDV RNA in heart
tissue (Ct = 23–33) and serum (Ct = 17–26), but had a
lower load of virus than pigs that died in the acute phase
of infection. The second set of pigs that survived until the
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end of the experiment included pigs that were past or al-
most past the acute phase of infection (id nos. 18, 19, 26,
27, 28, 29, 30, 31, 32). These pigs were negative or had low
levels of virus RNA by RT-PCR analysis for FMDV RNA
in both heart tissue and serum at this stage.
Sequencing of viral RNA isolated from serum and heart
tissue
Pigs within Groups 3 (O1K/O-UKG chimera) and 4 (O-
UKG/34/2001 field strain) were housed within the same
air space although they were well separated (by over
3 m); previous studies have shown that a physical gap of
70 cm [34] is sufficient to prevent spread of virus by
aerosol between pigs. However, we wanted to ensure
that the clinical results observed reflected the response
to the specific virus used for that Group. Thus, RNA
was extracted from serum and heart tissue samples and
used to amplify, by RT-PCR, fragments corresponding to
most of the VP1 coding region (ca. 520 bp), that is com-
mon to each of these viruses, and to part of the VP4/
VP2 coding region (ca. 820 bp), which includes the junc-
tion between the O1K B64 and the O-UKG capsid cod-
ing sequence in the chimera. As expected, the VP1
sequences were identical to the O-UKG/35/2001 se-
quence [GenBank: AJ539141] in each of the 3 samples
tested (from pigs with id nos. 23, 24 and 25). However,
around the junction between the VP4 and VP2 coding
sequences, RNA obtained from pigs with id nos. 23 and
24 (Group 3) matched the expected structure of the
O1K/O-UKG chimera while the sequence generated
from the pig with id no. 25 sample (Group 4) exactly
matched the O-UKG/35/2001 sequence (data not
shown). Thus these results indicated that these pigs had
indeed been infected with the expected virus.
Development of FMDV specific antibodies
Anti-FMDV specific antibodies were produced in pigs
which developed a systemic FMD infection and survived.
Three to five days after virus was detected in serum,
antibodies with the expected serotype specificity (O or
A) could be demonstrated. The diagnostic cut-off level,
defined as 45% (for serotype A) or 50% (for serotype O)
blocking of the serotype-specific antigen in ELISA, was
reached after 5–7 days (Figure 4). Contact pigs which
died acutely in the group of O1K/O-UKG infected pigs
did not survive long enough to develop such antibodies.
No antibodies were detected in animals that did not ex-
hibit signs of clinical disease.
Discussion
The pathogenicity in young pigs of 4 different, genetic-
ally defined, FMDVs has been compared. The properties
of the cell culture adapted O1K B64 virus and its
chimeric derivatives (O1K/O-UKG and O1K/A-TUR)
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have been investigated in cattle previously [15] while the
O/UKG/34/2001 field virus has been characterized in
separate studies in pigs [28,29] and cattle [27].
The cell culture adapted O1K B64 did not cause clin-
ical signs of FMD in pigs as was observed previously in
cattle [15]. Viral RNA in serum was only found at low
levels within one pig on a single day. It seems that this
HS-binding virus either does not reach the blood or else
is rapidly cleared from the circulation and thus does not
get the opportunity to spread and replicate within the
inoculated animals. In contrast, both the O1K/O-UKG
and the O1K/A-TUR chimeric viruses, which have cap-
sid proteins from field strains but are otherwise identical
to the O1K B64 virus, caused classical symptoms of
FMDV infection in pigs, albeit at different levels. The
O1K/O-UKG virus caused severe disease in pigs with
100% morbidity and an overall mortality of 50%, indeed
for the in-contact pigs mortality was 75%. These results
are similar to those seen in cattle [15] except that no
mortality was observed in this species. In contrast, the
O1K/A-TUR chimera showed much lower disease im-
pact in pigs (only 1 of the 4 inoculated animals showed
clinical signs) whereas in cattle 5 of 6 animals in the
group exposed to this chimera became infected within a
similar experiment [15]. Furthermore, one of the pigs
seemed to become infected with this chimeric virus late
in the experiment (as judged by the appearance of viral
RNA in serum, see Figure 2b) but due to the short time
perspective (the experiment was terminated after
10 days) development of clinical disease and possible
transmission to pen-mates could not be followed, how-
ever, signs of myocardial degeneration were observed in
this pig at autopsy. Therefore a higher morbidity rate for
the pigs might have been seen if this experiment had
been prolonged. Pigs inoculated with the field strain O-
UKG/34/2001 demonstrated severe clinical disease and
high levels of viral RNA in serum. Clinical signs (lame-
ness, severe vesicular lesions along coronary bands and
heel bulb area and to a lesser extent in the mouth re-
gion) closely resembled symptoms described in earlier
studies [28,29] and levels of viral RNA in serum (peak
concentrations of 1010 genome copies/mL) were very
high (c.f up to 109.7 genomes/mL determined by Quan
et al. [28]). This virus strain causes more severe disease
in pigs than in cattle [27,29].
A corresponding serotype specific antibody response
was developed in all pigs that became systemically
infected and then survived through the acute phase, irre-
spective of which virus or derivative the individual pig
was exposed to.
In this study we saw acute deaths in pigs exposed to the
O1K/O-UKG chimera. Three out of 4 contact pigs were
found dead in the pen shortly after initial clinical signs
were recorded. High amounts of viral RNA was found in
the heart (myocardium) of these pigs. Fatal FMD is often
associated with myocarditis, a phenomenon recognized to
occur only in young animals. In these cases macroscopical
examination of the heart often reveals a soft, flaccid heart
with white or greyish stripes, so-called “tiger heart”. How-
ever, there may be no significant macroscopical lesions,
but virus can usually be isolated from the myocardium [1].
It seems likely that acute myocarditis was the cause of
death in pigs in our study, even though no myocardial de-
generation was visually detected in these pigs (id nos. 17,
22, 23, 24), due to the high levels of FMDV RNA detected
in the heart of these animals. During the viraemic phase of
disease, virus can be found in all organs; therefore organs
should be regarded as sites of active viral replication only
when they show a higher concentration of virus or viral
RNA than found in blood at the same time [1]. In the
present study, the level of FMDV RNA in corresponding
serum and heart tissue samples was similar (as judged by
Ct levels). However, during the RNA preparation proced-
ure (for extraction and RT-PCR) the heart tissue samples
were diluted 1:10 for homogenization and therefore the
viral load in heart tissue should be regarded as even higher
than in serum. This indicates a specific secondary replica-
tion of virus in the heart musculature of these pigs and
was only observed in pigs that died in the acute phase of
infection. It is not clear why the O1K/O-UKG chimeric
virus should cause a higher rate of death than the parental
field strain (since the level of viral RNA reached in serum
was similar) but this may just be a consequence of the
relatively small number of animals involved. Interestingly,
one contact pig (id no. 11) from Group 2, infected with
the other chimeric virus (O1K/A-TUR), showed macro-
scopic lesions compatible with myocardial degeneration
and could have been a candidate for myocardial infarction.
Viral RNA in oral swab samples was found at low levels in
several pigs which were not going through a systematic
FMDV infection, especially in pigs from Group 2 inocu-
lated with the O1K/A-TUR chimera. This probably repre-
sents background environmental virus that had been
inhaled and trapped in the respiratory tract originating
from the single pig which developed clinical disease.
In Groups 3 and 4, the majority of the pigs inoculated
with virus (the O1K/O-UKG chimera or the O-UKG/34/
2001 field strain, respectively) developed disease on dpi
2–4. However, 2 pigs (id nos. 20 and 29) developed dis-
ease at dpi 9 and dpi 5, respectively, i.e. in the same time
interval as the in-contacts, which developed disease
from dpi 5 and onwards. Whether these 2 inoculated
pigs responded late to the inoculated virus or should be
regarded as contact infected pigs cannot be determined.
Continuing epidemics of FMDV infection in large
parts of the world, remind us of the necessity of still put-
ting effort into FMDV research in order to broaden our
knowledge regarding the pathogenicity of this virus and
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the specific host-virus interactions which underlie this.
The chimeric viruses used here provide a useful tool to
determine the influence of the capsid proteins alone on
the properties of virus and the experiments in the nat-
ural host animals are critical for understanding how
these factors determine the outcome of virus infection.
Since the O1K B64, O1K/O-UKG and O1K/A-TUR
viruses are genetically identical except for their capsid
protein coding regions, but differ markedly in their abil-
ity to induce disease, the clear conclusion from these
studies is that these capsid proteins are determinants of
FMDV pathogenicity in swine.
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